Summary
72 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 12% a year over the last 3 years.
- Out of every 100 USD of revenue, 29 USD is left as net profit.
- It has raised its dividend 12 years in a row.
- It earns 14 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue growth is slowing: 3.7% a year over the last 3 years against 7.7% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Beverages - Non-Alcoholic)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.5 USD for 1 USD of yearly profit. Over the last five years it was 25.5 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.7% a year over 5 years. Over the last 3 years it grew by 3.7% a year. For the next fiscal year analysts expect revenue to grow by 3.9%. Earnings per share grew by 12% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 38 USD
- Sales and administration 32 USD
- Taxes and other 1.1 USD
- Net profit 29 USD
Net profit, industry median (Beverages - Non-Alcoholic) 21 USD
Out of every 100 USD of revenue, 29 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 2.39%
- Paid out of profit
- 63%
- Raised in a row
- 12 years
You receive $2.10 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 29
- Hold 16
- Sell 3
Today's price within the analysts' price targets
The average target of $95.75 is 6.6% above today's price. 60% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Concentrate operations 59%
- Finished product operations 41%
By region
- North America 62%
- Latin America 20%
- Pacific 18%
Concentrate operations brings in 59% of revenue.
Segments in detail